High Tide Inc
High Tide Inc operates in the pharmaceuticals industry within the Health Care sector, though specific operational details and revenue sources are not disclosed in the available data.
Business. High Tide Inc (HITI.O) is a health care company operating within the pharmaceuticals industry. The firm is headquartered in Canada and is primarily listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
1Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
High Tide Inc (HITI.O) has experienced no material changes in its operational or financial profile relative to prior analysis. A comprehensive review of 17 key fields confirmed the absence of significant developments, with only four schema-expansion fields excluded from this assessment. Consequently, there are no new events, figures, or strategic shifts to report for the company at this time. The lack of material change is further underscored by a complete absence of market signals. Watcher signals are empty, and cross-source data indicates zero dispatches per day over the 30-day period ending in July 2026. This silence suggests a period of low activity or visibility in the news cycle and market commentary surrounding the stock. From a structural perspective, High Tide Inc currently lists zero officers, zero analysts, and zero index memberships. The company’s ownership structure is characterized by a top holder count of two. These static metrics provide the baseline context for the current lack of dynamic changes, reflecting a stable but inactive corporate footprint in the available data. Given the absence of new material information, the significance of this period lies in its continuity rather than transformation. Investors and observers should note that the company’s status remains unchanged, with no new catalysts identified in the recent data window. The available financial and estimate citations [doc:hiti.o-ha-financials] [doc:hiti.o-ha-estimates] remain the primary reference points, as no new developments have altered the existing narrative.
Signals & dispatch
Composite-score breakdown
Synthesis
High Tide Inc (HITI.O) is a health care company operating within the pharmaceuticals industry. The firm is headquartered in Canada and is primarily listed on the NASDAQ stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
(a) Capital structure and liquidity cannot be fully assessed due to the absence of balance-sheet line items such as cash, debt, or current liabilities in the provided data. The company has 87,235,986 basic and diluted shares outstanding, indicating no immediate dilution from options or warrants in the current snapshot. The market capitalization stands at approximately $193.7 million, derived from a share price of $2.22. Without balance-sheet inputs, liquidity risk remains unknown, and no going-concern language was identified in source documents.
(b) Profitability and return metrics are not available in the valuation snapshot, as key ratios such as P/E, ROE, ROA, and EV/EBITDA are absent. Consequently, comparisons to cohort medians or industry benchmarks for profitability cannot be made. The lack of financial performance data prevents an assessment of the company’s economic quality or margin profile relative to peers.
High Tide Inc (HITI.O) has experienced no material changes in its operational or financial profile relative to prior analysis. A comprehensive review of 17 key fields confirmed the absence of significant developments, with only four schema-expansion fields excluded from this assessment. Consequently, there are no new events, figures, or strategic shifts to report for the company at this time. The lack of material change is further underscored by a complete absence of market signals. Watcher signals are empty, and cross-source data indicates zero dispatches per day over the 30-day period ending in July 2026. This silence suggests a period of low activity or visibility in the news cycle and market commentary surrounding the stock. From a structural perspective, High Tide Inc currently lists zero officers, zero analysts, and zero index memberships. The company’s ownership structure is characterized by a top holder count of two. These static metrics provide the baseline context for the current lack of dynamic changes, reflecting a stable but inactive corporate footprint in the available data. Given the absence of new material information, the significance of this period lies in its continuity rather than transformation. Investors and observers should note that the company’s status remains unchanged, with no new catalysts identified in the recent data window. The available financial and estimate citations [doc:hiti.o-ha-financials] [doc:hiti.o-ha-estimates] remain the primary reference points, as no new developments have altered the existing narrative.
- Liquidity risk is unassessable due to missing balance-sheet data, creating uncertainty around short-term solvency.
- Dilution risk is low, with basic and diluted shares outstanding being identical.
- Analyst price targets of 6.74 CAD imply substantial upside from the current USD 2.22 share price.
- Profitability, growth, and segment data are entirely absent, limiting fundamental analysis.
- The company is classified in Pharmaceuticals with high confidence (0.85), but operational details are not disclosed.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue $179.3M, +30,1% YoY; Operating income +687,7% YoY.
- ▍Revenue $179.3M, +30,1% YoY
- ▍Operating income +687,7% YoY
- ▍Net income +93,2% YoY
- ▍Free cash flow +812,4% YoY
- ▍Net margin -0.1%
Revenue $178.3M, +25,2% YoY; Operating income −4,3% YoY.
- ▍Revenue $178.3M, +25,2% YoY
- ▍Operating income −4,3% YoY
- ▍Net income +142,9% YoY
- ▍Free cash flow +1 189,0% YoY
- ▍Net margin 0.7%
Revenue $164.0M, +18,6% YoY; Operating income −506,8% YoY.
- ▍Revenue $164.0M, +18,6% YoY
- ▍Operating income −506,8% YoY
- ▍Net income −873,3% YoY
- ▍Free cash flow −2 878,1% YoY
- ▍Net margin -27.8%
Revenue $149.7M, +13,7% YoY; Operating income −6,1% YoY.
- ▍Revenue $149.7M, +13,7% YoY
- ▍Operating income −6,1% YoY
- ▍Net income −16,6% YoY
- ▍Free cash flow +57,8% YoY
- ▍Net margin 0.4%
Revenue $137.8M; Operating income -$684.0k.
- ▍Revenue $137.8M
- ▍Operating income -$684.0k
- ▍Net margin -2.1%
Revenue $142.5M; Operating income -$563.0k.
- ▍Revenue $142.5M
- ▍Operating income -$563.0k
- ▍Net margin -2.0%
Revenue $138.3M; Operating income -$3.6M.
- ▍Revenue $138.3M
- ▍Operating income -$3.6M
- ▍Net margin -3.4%
Revenue $131.7M; Operating income $3.0M.
- ▍Revenue $131.7M
- ▍Operating income $3.0M
- ▍Net margin 0.5%
Revenue $594.0M, +13,7% YoY; Operating income −1 137,2% YoY.
- ▍Revenue $594.0M, +13,7% YoY
- ▍Operating income −1 137,2% YoY
- ▍Net income −1 070,1% YoY
- ▍Free cash flow −419,0% YoY
- ▍Net margin -8.5%
Revenue $522.3M, +7,1% YoY; Operating income +104,7% YoY.
- ▍Revenue $522.3M, +7,1% YoY
- ▍Operating income +104,7% YoY
- ▍Net income +89,0% YoY
- ▍Free cash flow +182,9% YoY
- ▍Net margin -0.8%
Revenue $487.7M, +36,7% YoY; Operating income +42,8% YoY.
- ▍Revenue $487.7M, +36,7% YoY
- ▍Operating income +42,8% YoY
- ▍Net income +45,2% YoY
- ▍Free cash flow +71,2% YoY
- ▍Net margin -8.1%
Revenue $356.9M, +97,0% YoY; Operating income −303,4% YoY.
- ▍Revenue $356.9M, +97,0% YoY
- ▍Operating income −303,4% YoY
- ▍Net income −100,9% YoY
- ▍Free cash flow −123,7% YoY
- ▍Net margin -20.1%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,02 |
| Revenue | —no estimate | —no estimate | 732,4M CAD |
| Operating income | —no estimate | —no estimate | 22,1M CAD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Market Capmarket_price * shares_outstanding_diluted
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Cash Conversion Ratiooperating_cash_flow / net_income
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Capex To Revenuecapital_expenditure / revenue
- HIGH TIDE INC. Market data — financials · 2026-07-21
- High Tide Inc Market data — analyst estimates · 2026-07-21
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M